<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>344</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11289284</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>Breast cancer (BRCA) has become the most common type of cancer in women. Improving the therapeutic response remains a challenge. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is a classic tumour suppressor with emerging new functions discovered in recent years, and myeloid PTEN loss has been reported to impair antitumour immunity. In this study, we revealed a novel mechanism by which myeloid PTEN potentially affects antitumour immunity in BRCA. We detected accelerated stress granule (SG) assembly under oxidative stress in PTEN-deficient bone marrow-derived macrophages (BMDMs) through the EGR1-promoted upregulation of TIAL1 transcription. PI3K/AKT/mTOR (PAM) pathway activation also promoted SG formation. ATP consumption during SG assembly in BMDMs impaired the phagocytic </pubmed_abstract><journal>Cell death discovery</journal><pubmed_title>Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancer.</pubmed_title><pmcid>PMC11289284</pmcid><funding_grant_id>82172775</funding_grant_id><funding_grant_id>82102905</funding_grant_id><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Feng X</pubmed_authors><pubmed_authors>Dong M</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Qian X</pubmed_authors><pubmed_authors>Hua H</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Han C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancer.</name><description>Breast cancer (BRCA) has become the most common type of cancer in women. Improving the therapeutic response remains a challenge. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is a classic tumour suppressor with emerging new functions discovered in recent years, and myeloid PTEN loss has been reported to impair antitumour immunity. In this study, we revealed a novel mechanism by which myeloid PTEN potentially affects antitumour immunity in BRCA. We detected accelerated stress granule (SG) assembly under oxidative stress in PTEN-deficient bone marrow-derived macrophages (BMDMs) through the EGR1-promoted upregulation of TIAL1 transcription. PI3K/AKT/mTOR (PAM) pathway activation also promoted SG formation. ATP consumption during SG assembly in BMDMs impaired the phagocytic </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-01T16:19:56.195Z</modification><creation>2025-04-19T07:04:32.142Z</creation></dates><accession>S-EPMC11289284</accession><cross_references><pubmed>39080255</pubmed><doi>10.1038/s41420-024-02094-0</doi></cross_references></HashMap>